BioCentury | Apr 23, 2020
Finance

In Hong Kong’s largest biotech IPO of the year, antibody company Akeso raises $333M

...“Strong Investor Demand for InnoCare” ). Akeso’s offering was underwritten by Morgan Stanley, J.P. Morgan, BOCOM International...
BioCentury | Apr 18, 2020
Finance

April 17 Quick Takes: Mabworks’ $160M series C; plus RDMD, PIC, SIRS, Atomo and Lantern

...Huge Capital with participation by SDIC, Lake Bleu Capital, Yuexiu Industrial Fund, E-Town International Investment, BOCOM International...
BioCentury | Mar 9, 2020
Finance

GenFleet eyes proof of concept with $50M series B

...The round saw participation by new investors South China Venture Capital, Panlin Capital, Lake Capital, BOCOM International...
BioCentury | Nov 5, 2019
Financial News

Following JV, Sino backs Akeso's $150M series D

...Fund I LP, AIHC, OrbiMed, K. Wah Group, CCB Capital, Apricot Capital, Triwise Capital and BOCOM International...
BioCentury | Jun 25, 2019
Financial News

June 25 Financial Quick Takes: Tasly unit planning Hong Kong IPO; plus Vesalius, Mirati and more

...of the company’s equity. Other shareholders include Ally Bridge, Pudong Science and Technology, Southern Creation, BOCOM International...
BioCentury | Jul 11, 2018
Company News

Ally Bridge invests in Tasly Biopharmaceuticals

...IPO. The investors, which include Ally Bridge LB Healthcare Fund, Pudong Technology (Cayman) Co. Ltd., BOCOM International...
Items per page:
1 - 6 of 6
BioCentury | Apr 23, 2020
Finance

In Hong Kong’s largest biotech IPO of the year, antibody company Akeso raises $333M

...“Strong Investor Demand for InnoCare” ). Akeso’s offering was underwritten by Morgan Stanley, J.P. Morgan, BOCOM International...
BioCentury | Apr 18, 2020
Finance

April 17 Quick Takes: Mabworks’ $160M series C; plus RDMD, PIC, SIRS, Atomo and Lantern

...Huge Capital with participation by SDIC, Lake Bleu Capital, Yuexiu Industrial Fund, E-Town International Investment, BOCOM International...
BioCentury | Mar 9, 2020
Finance

GenFleet eyes proof of concept with $50M series B

...The round saw participation by new investors South China Venture Capital, Panlin Capital, Lake Capital, BOCOM International...
BioCentury | Nov 5, 2019
Financial News

Following JV, Sino backs Akeso's $150M series D

...Fund I LP, AIHC, OrbiMed, K. Wah Group, CCB Capital, Apricot Capital, Triwise Capital and BOCOM International...
BioCentury | Jun 25, 2019
Financial News

June 25 Financial Quick Takes: Tasly unit planning Hong Kong IPO; plus Vesalius, Mirati and more

...of the company’s equity. Other shareholders include Ally Bridge, Pudong Science and Technology, Southern Creation, BOCOM International...
BioCentury | Jul 11, 2018
Company News

Ally Bridge invests in Tasly Biopharmaceuticals

...IPO. The investors, which include Ally Bridge LB Healthcare Fund, Pudong Technology (Cayman) Co. Ltd., BOCOM International...
Items per page:
1 - 6 of 6